TODD M BAZEMORE's Planned Sale of KALA BIO, Inc. Securities

TODD M BAZEMORE, an officer of KALA BIO, Inc., has filed a Form 144 notice indicating the planned sale of 47,768 common shares of KALA BIO, Inc. These shares were acquired through the vesting of restricted stock and performance shares between June 25, 2021, and October 26, 2022. The sale is expected to occur on or around October 22, 2025, with an aggregate market value of approximately $39,685.65. The shares will be sold through Morgan Stanley Smith Barney LLC Executive Financial Services. No securities were sold in the past three months.